The Haematology and Trauma Working Group of the National Blood Transfusion Committee (NBTC) will launch the 2026 re‑audit on the reversal of anticoagulant‑associated bleeding on Tuesday 5 May. This follows the initial audit undertaken between 1 January and 31 March 2022, which explored organisational guidance and case management for DOAC and VKA‑associated bleeding in trauma settings.
Audits and Surveys for Midlands
Proposals are to be agreed by your Regional Transfusion Committee (RTC) and your Patient Blood Management Practioner, then email the audit manager (brian.hockley@nhsbt.nhs.uk) to progress.
Proposals can be submitted online at: RTC Clinical Audit-Survey Proposals Submission Form
Current activity
Audit Series on Anticoagulant Reversal in Trauma and Anticoagulant Associated Bleeding
| Attachment | Size |
|---|---|
| 2026 Instruction for Completion - VIT K and DOAC Audits on behalf of Haematology and Trauma WG | 165.17 KB |
| Template for DOAC Linkage 2026 | 34.5 KB |
| Template for Vit K Linkage 2026 | 34.62 KB |
Audit Series on Anticoagulant Reversal in Trauma and Anticoagulant Associated Bleeding
The Haematology and Trauma Working Group of the National Blood Transfusion Committee (NBTC) will launch the 2026 re‑audit on the reversal of anticoagulant‑associated bleeding on Tuesday 5 May. This follows the initial audit undertaken between 1 January and 31 March 2022, which explored organisational guidance and case management for DOAC and VKA‑associated bleeding in trauma settings.
| Attachment | Size |
|---|---|
| 2026 Instruction for Completion - VIT K and DOAC Audits on behalf of Haematology and Trauma WG | 165.17 KB |
| Template for DOAC Linkage 2026 | 34.5 KB |
| Template for Vit K Linkage 2026 | 34.62 KB |
Audit Series on Anticoagulant Reversal in Trauma and Anticoagulant Associated Bleeding
The Haematology and Trauma Working Group of the National Blood Transfusion Committee (NBTC) will launch the 2026 re‑audit on the reversal of anticoagulant‑associated bleeding on Tuesday 5 May. This follows the initial audit undertaken between 1 January and 31 March 2022, which explored organisational guidance and case management for DOAC and VKA‑associated bleeding in trauma settings.
| Attachment | Size |
|---|---|
| 2026 Instruction for Completion - VIT K and DOAC Audits on behalf of Haematology and Trauma WG | 165.17 KB |
| Template for DOAC Linkage 2026 | 34.5 KB |
| Template for Vit K Linkage 2026 | 34.62 KB |
Audit Series on Anticoagulant Reversal in Trauma and Anticoagulant Associated Bleeding
The Haematology and Trauma Working Group of the National Blood Transfusion Committee (NBTC) will launch the 2026 re‑audit on the reversal of anticoagulant‑associated bleeding on Tuesday 5 May. This follows the initial audit undertaken between 1 January and 31 March 2022, which explored organisational guidance and case management for DOAC and VKA‑associated bleeding in trauma settings.
| Attachment | Size |
|---|---|
| 2026 Instruction for Completion - VIT K and DOAC Audits on behalf of Haematology and Trauma WG | 165.17 KB |
| Template for DOAC Linkage 2026 | 34.5 KB |
| Template for Vit K Linkage 2026 | 34.62 KB |
Audit Series on Anticoagulant Reversal in Trauma and Anticoagulant Associated Bleeding
The Haematology and Trauma Working Group of the National Blood Transfusion Committee (NBTC) will launch the 2026 re‑audit on the reversal of anticoagulant‑associated bleeding on Tuesday 5 May. This follows the initial audit undertaken between 1 January and 31 March 2022, which explored organisational guidance and case management for DOAC and VKA‑associated bleeding in trauma settings.
| Attachment | Size |
|---|---|
| 2026 Instruction for Completion - VIT K and DOAC Audits on behalf of Haematology and Trauma WG | 165.17 KB |
| Template for DOAC Linkage 2026 | 34.5 KB |
| Template for Vit K Linkage 2026 | 34.62 KB |